Showing posts with label antitumor effects. Show all posts
Showing posts with label antitumor effects. Show all posts
Saturday, May 28, 2011
abstract: Pyridoxine (Vitamin B6) to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect
CONCLUSIONS:
Administration of pyridoxine (Vitamin B6) , at concentrations extending across possible therapeutic plasma levels in humans, does not antagonise OHP (Oxaliplatin) antitumour effects in a range of relevant tumour cell lines.
This study provides a foundation for clinical studies to test whether pyridoxine can minimise OHP-related neurotoxicity, and clinicians can be confident that pyridoxine is very unlikely to reverse the antitumour effects of OHP, as seems to be the case with Ca/Mg infusions.
This could prove to be a cost-effective way to minimise OHP-related neurotoxicity, allowing more effective less toxic treatment and better outcomes in patients.
add your opinions
antitumor effects
,
neurotoxicity
,
pyridoxine
,
vitamin b6
Subscribe to:
Posts
(
Atom
)